Co-Authors
This is a "connection" page, showing publications co-authored by Andreas Greinacher and Theodore Warkentin.
Connection Strength
2.420
-
Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thromb Res. 2021 08; 204:40-51.
Score: 0.950
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021 10 07; 138(14):1269-1277.
Score: 0.243
-
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. Blood. 2021 07 29; 138(4):299-303.
Score: 0.240
-
Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply. N Engl J Med. 2021 07 15; 385(3):e11.
Score: 0.238
-
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021 06 03; 384(22):2092-2101.
Score: 0.235
-
An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2019 03; 17(3):525-531.
Score: 0.202
-
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT. Blood. 2019 02 28; 133(9):978-989.
Score: 0.200
-
Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery. Am Heart J. 2010 Aug; 160(2):362-9.
Score: 0.112